These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

613 related articles for article (PubMed ID: 19001332)

  • 1. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.
    Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration
    J Clin Oncol; 2008 Dec; 26(35):5802-12. PubMed ID: 19001332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis.
    Chemoradiotherapy for Cervical Cancer Meta-analysis Collaboration (CCCMAC)
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD008285. PubMed ID: 20091664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women.
    Park JH; Kim YS; Ahn SD; Choi EK; Shin SS; Kim YT; Kim YM; Kim JH; Yi SY; Nam JH
    Tumori; 2010; 96(6):959-65. PubMed ID: 21388059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.
    Green J; Kirwan J; Tierney J; Symonds P; Fresco L; Williams C; Collingwood M
    Cochrane Database Syst Rev; 2001; (4):CD002225. PubMed ID: 11687152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.
    Green J; Kirwan J; Tierney J; Vale C; Symonds P; Fresco L; Williams C; Collingwood M
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD002225. PubMed ID: 16034873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Rosa DD; Medeiros LR; Edelweiss MI; Bozzetti MC; Pohlmann PR; Stein AT; Dickinson HO
    Cochrane Database Syst Rev; 2009 Jul; (3):CD005342. PubMed ID: 19588370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant Efficacy of Additional Concurrent Chemotherapy with Radiotherapy for Postoperative Cervical Cancer with Risk Factors: a Systematic Review and Meta-analysis.
    Qin AQ; Liang ZG; Ye JX; Li J; Wang JL; Chen CX; Song HL
    Asian Pac J Cancer Prev; 2016; 17(8):3945-51. PubMed ID: 27644643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
    Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.
    Green JA; Kirwan JM; Tierney JF; Symonds P; Fresco L; Collingwood M; Williams CJ
    Lancet; 2001 Sep; 358(9284):781-6. PubMed ID: 11564482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
    Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
    de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; Colombo A; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Carinelli S; Provencher D; Hanzen C; Lutgens LCHW; Smit VTHBM; Singh N; Do V; D'Amico R; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
    Lancet Oncol; 2018 Mar; 19(3):295-309. PubMed ID: 29449189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
    Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
    Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evidence based of chemoradiotherapy in cervix carcinoma].
    Joly-Lobbedez F
    Cancer Radiother; 2009 Oct; 13(6-7):503-6. PubMed ID: 19695934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer.
    Kirwan JM; Symonds P; Green JA; Tierney J; Collingwood M; Williams CJ
    Radiother Oncol; 2003 Sep; 68(3):217-26. PubMed ID: 13129628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.
    Rossi A; Chiodini P; Sun JM; O'Brien ME; von Plessen C; Barata F; Park K; Popat S; Bergman B; Parente B; Gallo C; Gridelli C; Perrone F; Di Maio M
    Lancet Oncol; 2014 Oct; 15(11):1254-62. PubMed ID: 25232001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Angeles MA; Baissas P; Leblanc E; Lusque A; Ferron G; Ducassou A; Martínez-Gómez C; Querleu D; Martinez A
    Int J Gynecol Cancer; 2019 Mar; 29(3):480-486. PubMed ID: 30712019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.
    Kim HS; Sardi JE; Katsumata N; Ryu HS; Nam JH; Chung HH; Park NH; Song YS; Behtash N; Kamura T; Cai HB; Kim JW
    Eur J Surg Oncol; 2013 Feb; 39(2):115-24. PubMed ID: 23084091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adjuvant chemoradiotherapy versus radiotherapy in early-stage cervical cancer patients with intermediate-risk factors: A systematic review and meta-analysis.
    Guo Q; Wang R; Jin D; Yin Z; Hu B; Li R; Wu D
    Taiwan J Obstet Gynecol; 2022 Jan; 61(1):15-23. PubMed ID: 35181028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.